2019
DOI: 10.1002/pmic.201900025
|View full text |Cite
|
Sign up to set email alerts
|

Tspan15 Is a New Stemness‐Related Marker in Hepatocellular Carcinoma

Abstract: Hepatocellular carcinoma (HCC) is the second cause of cancer‐related deaths worldwide. A clearer understanding of the molecular mechanisms underlying tumor growth and invasiveness remains crucial for developing new therapies. Here, the expression of tetraspanins, a family of plasma membrane organizers involved in tumor progression, has been addressed. Integrative approaches combining transcriptomics and bioinformatics allow demonstrating the induced and heterogeneous expression of Tspan15 in HCC. Tspan15 posit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
26
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(29 citation statements)
references
References 68 publications
3
26
0
Order By: Relevance
“…Indeed, ADAM10 was almost 400 times more abundant in Tspan15 immunoprecipitates from wild-type cells versus control Tspan15-knockout cells, and the only other protein identified above the false discovery rate threshold was Tspan15 itself. These data are consistent with two previous studies in which GFP-tagged Tspan15 was expressed in U2OS or HepG2 cells, which were lysed in relatively non-stringent 1% Brij97 and Tspan15 immunoprecipitated via the GFP tag (Jouannet et al 2016; Sidahmed-Adrar et al 2019). For example, mass spectrometry identified ADAM10 as 15-fold more abundant than any other Tspan15-interacting proteins (Jouannet et al 2016).…”
Section: Discussionsupporting
confidence: 92%
See 2 more Smart Citations
“…Indeed, ADAM10 was almost 400 times more abundant in Tspan15 immunoprecipitates from wild-type cells versus control Tspan15-knockout cells, and the only other protein identified above the false discovery rate threshold was Tspan15 itself. These data are consistent with two previous studies in which GFP-tagged Tspan15 was expressed in U2OS or HepG2 cells, which were lysed in relatively non-stringent 1% Brij97 and Tspan15 immunoprecipitated via the GFP tag (Jouannet et al 2016; Sidahmed-Adrar et al 2019). For example, mass spectrometry identified ADAM10 as 15-fold more abundant than any other Tspan15-interacting proteins (Jouannet et al 2016).…”
Section: Discussionsupporting
confidence: 92%
“…Interestingly, gene expression data suggests that Tspan15 is strongly upregulated in cholangiocarcinoma and pancreatic adenocarcinoma (Tang et al 2019), and is a marker of poor prognosis in pancreatic, renal and liver cancer (Uhlen et al 2017). Moreover, Tspan15 has been recently implicated in oral squamous cell carcinoma (Hiroshima et al 2019) and hepatocellular carcinoma (Sidahmed-Adrar et al 2019).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…To achieve this goal, we analyzed the expression of 33 TSPAN family proteins in 21 common tumors through the public database Oncomine, and we focused on their role in 3 common digestive tract tumors. TSPAN15 is believed to enhance tumor stemness, and it has the ability to promote tumor growth and recurrence [30]. TSPAN12 can promote tumor cell proliferation and colony formation, and high expression of CD9 is considered to be related to lymph node metastasis [31,32].…”
Section: Discussionmentioning
confidence: 99%
“…TSPAN15 is believed to enhance tumor stemness, and it has the ability to promote tumor growth and recurrence [20] . TSPAN12 can promote tumor cell proliferation and colony formation, and high expression of CD9 is considered to be related to lymph node metastasis [21,22] .…”
Section: Discussionmentioning
confidence: 99%